MSD Australia is a subsidiary of Merck & Co., Inc., a global pharmaceutical leader. The company focuses on research, development, and distribution of medicines and vaccines to address significant health challenges. Their website reflects a mature digital presence with comprehensive content targeting patients, healthcare professionals, and researchers. The site emphasizes corporate responsibility, patient well-being, and innovation in healthcare.
Technically, the website is built on WordPress with modern SEO and accessibility practices. It employs Google Tag Manager and OneTrust for analytics and cookie consent, indicating a commitment to privacy compliance. The site is mobile-optimized and performs moderately well, with a professional design and clear navigation.
From a security perspective, the site uses HTTPS with strong security headers and no visible vulnerabilities. However, there is no publicly available security policy or incident response contact, which could be improved. WHOIS data is privacy-protected, common for large enterprises, and does not raise immediate concerns. Overall, the site demonstrates a strong security posture and compliance with privacy regulations.
The overall risk is low, with recommendations to enhance transparency around security policies and incident response. The website is trustworthy and professionally managed, supporting MSD Australia's market position as a leading healthcare provider.
Scanned ·
NIS2 and GDPR posture
GDPR outside view
68/ 100 · Medium
Checks completed
7of 7
NIS2 Art. 21(2)
a(a) Risk analysis and security policies: Not visible from outside
b(b) Incident handling: One indicator
c(c) Business continuity, backups and crisis management: Not visible from outside
d(d) Supply chain security: Not visible from outside
e(e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
f(f) Assessing the effectiveness of security measures: Not visible from outside
g(g) Cyber hygiene and security training: Not visible from outside
h(h) Cryptography and encryption: Partly checked
i(i) HR security, access control and asset management: One indicator
j(j) Multi-factor authentication and secured communications: Not visible from outside
Partly checked
One indicator
Not visible from outside
This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.
GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.
Priority findings
3 findings rated critical or high. Fix these first.
GDPR outside view
These are the privacy signals visitors and data protection authorities look for under GDPR.
High
No Cookie Consent Banner found
GDPR requires explicit consent for non-essential cookies
What to do: Implement a cookie consent banner that appears on first visit
This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.
Daily monitoring
Recommended
€25per month
TLS certificates and expiry
DNS records
SPF, DKIM and DMARC
Security headers
GDPR and NIS2 posture
Exposed services
Third-party trackers
Security score drift
Email alerts on material changes and an exportable JSON history of every change.
Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.
Full report
€39.90one-time
The complete analysis as a PDF you can cite
Email delivery with an unlock code
Lifetime access to this report
Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.
Results by check
Each check with its score, findings and the evidence it collected.
How this score is calculated
The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.
Counted in this score
SSL/TLS
42
Security headers
80
Email security
70
DNS health
75
Network security
100
GDPR outside view
68
Average
73
Not counted
NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.
Findings that cap the score at 49
Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.
The certificate is not trusted by browsers
The website is not served over HTTPS
A database, remote desktop, file-sharing or Telnet service is reachable from the internet
The page loads a script from a compromised source
The domain registration has expired
SPF authorises every server to send mail as the domain
Partial scans
When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.
Risk levels
Critical0–25
High26–49
Medium50–75
Low76–100
Breach exposure
Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.
Dark web exposure
Add-on
Leaked records that mention msd-australia.com.au, from OffSeq Breach.
No leaked records found
Breach holds no records for msd-australia.com.au right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.
Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.
Business context
Business profile
MSD Australia operates in the healthcare sector as a subsidiary of Merck & Co., Inc. It leverages a global brand and extensive research capabilities to maintain a strong market position. The business model centers on pharmaceutical innovation, patient support, and corporate social responsibility. The company targets healthcare professionals, patients, and communities, with a focus on vaccines and medicines. The website's extensive network of related domains and partner sites reflects a broad partnership ecosystem. Growth indicators include active content updates and engagement through social media. The company maintains a professional and consistent brand image, supporting its enterprise status in the pharmaceutical industry.
Security posture
The website exhibits a mature security posture with HTTPS enforcement and multiple security headers. The use of cookie consent mechanisms and privacy policies aligns with GDPR and Australian privacy laws. No exposed sensitive data or vulnerable libraries were detected. However, the absence of a dedicated security policy page and incident response contacts limits transparency. There is no evidence of a vulnerability disclosure program or security.txt file. Overall, the site is secure but could improve by publishing explicit security policies and providing clear incident response channels to enhance trust and compliance.
Recommendations
Publish a dedicated security policy page outlining security practices and commitments.
Provide clear incident response contact information, such as security@ or abuse@ email addresses.
Implement a vulnerability disclosure program and publish a security.txt file to encourage responsible reporting.
Regularly review and audit third-party scripts and plugins to mitigate potential vulnerabilities.
Enhance transparency by providing contact details for the Data Protection Officer or privacy lead.
Automated reading of the public site. Ratings are indicative.
Business
Company
Merck Sharp & Dohme (Australia) Pty Ltd
Description
MSD Australia follows the science to tackle some of the world's greatest health threats, providing medications and vaccines to improve lives.
Key services
Pharmaceutical products, Vaccines, Research and development, Patient support
Content quality
excellent
Branding
consistent
Technology
Stack
WordPress, Yoast SEO, Tiny Slider, Google Tag Manager, OneTrust Cookie Consent
Platforms
WordPress
Performance
moderate
Mobile
excellent
Accessibility
good
SEO
good
Security
Observed score
85/100
Good practices seen
HTTPS enforced
Cookie consent mechanism
No exposed sensitive data in HTML
Use of Google Tag Manager for controlled script loading
Analytics and tracking
Services
Google Analytics (via Google Tag Manager)
Tracking level
moderate
Privacy practices
good
Advertising
Transparency
good
Site quality
Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high
Key observations
Website is fully accessible with no blocking or WAF challenges.
Content is professionally presented and relevant to healthcare and pharmaceuticals.
Strong privacy and cookie policies with consent mechanisms are in place.
No exposed sensitive data or obvious security vulnerabilities detected.
WHOIS data is unavailable, likely due to privacy protection, which is common for large enterprises.
Multiple external domains linked are legitimate MSD or Merck related sites.
Social media presence on Twitter and LinkedIn is active and linked.
Website uses modern technologies and SEO best practices.
Technical notes
Notes
The website is built on WordPress, utilizing Yoast SEO for search optimization and Tiny Slider for interactive content. Google Tag Manager is used for analytics and marketing scripts, while OneTrust manages cookie consent, indicating compliance with privacy regulations. The site is mobile-optimized with responsive images and accessible design features. Performance is moderate, with potential for improvement in loading speed. The technical stack is modern and well-maintained, supporting a professional user experience. No deprecated or vulnerable technologies were detected in the provided content.
Standards and sources
Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.
Reviews of this site
Share your experience with msd-australia.com.au. Every review is verified by email and published after moderation.
Community rating
No published reviews yet. Be the first to review msd-australia.com.au.